Long treatment with strontium ranelate of womenwith postmenopausal osteoporosis: 10-year results

Long treatment with strontium ranelate of womenwith postmenopausal osteoporosis: 10-year results

Bibliographic Details
Main Authors:	J Y Reginster, J M Kaufman, S Goemaere, C L Benhamou, A Balogh, C Albanese, J Badurski, C Roux
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2011-04-01
Series:	Остеопороз и остеопатии
Online Access:	https://endojournals.ru/index.php/osteo/article/view/4133

Similar Items

Strontium ranelate in the treatment of postmenopausal osteoporosis: results of administration in clinical practice
by: N V Toroptsova, et al.
Published: (2008-06-01)

Pathogenetic treatment with strontium ranelate in women with postmenopausal osteoporosis
by: Olga Borisovna Yershova
Published: (2010-12-01)

Bivalos (strontium ranelate) administration experience in postmenopausal osteoporosis
by: I A Skripnikova, et al.
Published: (2009-04-01)

EFFICACY AND SAFETY OF STRONTIUM RANELATE IN THE TREATMENT OF MALE OSTEOPOROSIS
by: J M Kaufman, et al.
Published: (2012-08-01)

Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
by: Roberto Cesareo, et al.
Published: (2009-12-01)

LONG-TERM BENEFICIAL EFFECTS OF STRONTIUM RANELATE ON THEQUALITY OF LIFE IN PATIENTS WITH VERTEBRAL OSTEOPOROSIS (SOTI STUDY)
by: P MARQUIS, et al.
Published: (2007-08-01)

Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
by: Kurtuluş Kaya, et al.
Published: (2009-12-01)

Ischaemic cardiac events and use of strontium ranelate in postmenopausal osteoporosis: a nested case-control in the CPRD
by: Cooper, C., et al.
Published: (2014)

Social implication, economic aspects and new abilities of strontium ranelate in pharmacotherapy for postmenopausal osteoporosis
by: I S Dydykina, et al.
Published: (2008-09-01)

Social implication, economic aspects and new abilities of strontium ranelate in pharmacotherapy for postmenopausal osteoporosis
by: I S Dydykina, et al.
Published: (2008-09-01)

STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
by: Nataliya Vladimirovna Toroptsova
Published: (2010-09-01)

STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
by: Nataliya Vladimirovna Toroptsova
Published: (2010-09-01)

POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION
by: N. J. Hozjainova, et al.
Published: (2016-01-01)

POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION
by: N. J. Hozjainova, et al.
Published: (2016-01-01)

THE PLACE OF STRONTIUM RANELATE IN THE TREATMENT OF PATIENTS WITH OSTEOPOROSIS (RESULTS OF THE MARC PROGRAM)
by: O. A. Nikitinskaya, et al.
Published: (2018-09-01)

Comparison of the Effects of Strontium Ranelate and Raloxiphene on Bone Mineral Density in Postmenopausal Osteoporosis - Original Investigation
by: Figen Yılmaz, et al.
Published: (2009-04-01)

The Short-Term Effects of Strontium Ranelate on Pain and Bone Mineral Density in Postmenopausal Women with Osteoporosis
by: Halil Koyuncu, et al.
Published: (2012-08-01)

Strontium ranelate in the treatment of osteoporosis: evidence for its efficacy
by: N V Toroptsova, et al.
Published: (2010-02-01)

STRONTIUM RANELATE PREVENTS SPINE OSTEOARTHRITIS PROGRESSION IN PATIENTS WITH PREVALENT SPINAL OSTEOARTHRITIS
by: O Bruyere, et al.
Published: (2007-08-01)

PLEIOTROPIC EFFECTS OF THE BONE METABOLISM MODULATOR - STRONTIUM RANELATE IN TREATMENT OF WOMEN WITH THE POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION.
by: N. Yu. Khozyainova, et al.
Published: (2010-04-01)

A review of osteoporosis treatment with strontium ranelate in hospital Melaka
by: M.A.A. Sahadun, et al.
Published: (2017-09-01)

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
by: Jean-Yves Reginster, et al.
Published: (2014-02-01)

STRONTIUM RANELATE DECREASES VERTEBRAL FRACTURE RISK WHATEVER THE LEVEL OF PRETREATMENT BONE TURNOVER MARKERS
by: J COLLETTE, et al.
Published: (2007-08-01)

Polymeric strontium ranelate nonahydrate
by: Kenny Stahl, et al.
Published: (2011-04-01)

The Comparison of the Effect of Risedronate and Strontium Ranelate on Bone Mineral Density in Postmenopausal Women
by: Figen Yılmaz, et al.
Published: (2012-08-01)

The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women
by: M Stevenson, et al.
Published: (2007-02-01)

History of cardiovascular events and cardiovascular risk factors among patients initiating strontium ranelate for treatment of osteoporosis
by: Yu J, et al.
Published: (2015-11-01)

Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial
by: Cyrus Cooper, et al.
Published: (2013-12-01)

Osteoporosis: from cost-effect characteristics to clinical efficacy and safety of strontium ranelate (bivaios)
by: Ia S Dydykina, et al.
Published: (2008-05-01)

New promising avenue for the simvastatin combination with residronate, strontium ranelate and raloxifene in experimentally-induced osteoporosis
by: Amira K. Khalifa, et al.
Published: (2020-01-01)

Strontium ranelate is a drug to treat osteoarthrosis
by: Oksana Anatolyevna Nikitinskaya
Published: (2013-03-01)

PATHOGENESIS OF OSTEOARTHRITIS AND SUBSTANTIATION OF THE USE OF STRONTIUM RANELATE
by: Elena Mikhailovna Zaitseva, et al.
Published: (2014-02-01)

Secondary prevention of osteoporosis and osteoporotic fractures in real clinical practice and possibilities of its improvement with strontium ranelate
by: Nataliya Vladimirovna Toroptsova
Published: (2012-03-01)

STRONTIUM RANELATE DEMONSTRATES VERTEBRAL AND NON-VERTEBRAL ANTI FRACTURE EFFICACY INCLUDING HIP FRACTURES OVER 5 YEARS IN POST MENOPAUSAL OSTEOPOROTIC WOMEN
by: J Y REGINSTER, et al.
Published: (2007-08-01)

Effect of strontium ranelate on pain behavior in an experimental model of osteoarthritis
by: T.A. Rodrigues, et al.

STRONTIUM RANELATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS: IMPACT OF VITAMIN D RECEPTOR AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 GENE POLYMORPHISMS ON BONE MINERAL DENSITY: A PILOT STUDY
by: M. Yu. Krylov, et al.
Published: (2017-07-01)

The Effect of Strontium Ranelate on Fracture Healing: An Animal Study
by: Ourania I. Koukou, et al.
Published: (2020-01-01)

Spontaneous reossification of the sella in transsphenoidal reoperation associated with strontium ranelate
by: Maria Mercedes Pineyro, et al.
Published: (2017-07-01)

Strontium ranelate improves alveolar bone healing in osteopenic rats /
by: Momesso, Gustavo Antonio Correa.
Published: (2017)

Strontium ranelate improves alveolar bone healing in osteopenic rats
by: Momesso, Gustavo Antonio Correa [UNESP]
Published: (2017)